Introduction
Hypertension (HT) is an emerging risk factor that causes more than 7 million premature deaths a year worldwide, and that is becoming more prevalent in developing nations (1) . HT can lead to coronary heart disease, stroke, congestive
In China, HT is a common health problem with rising prevalence (5) . It was estimated that there were more than 94 million hypertensive patients in 1990, compared with 59 million in 1980, and 30 million in 1960 (6) . According to the Nation Wide Survey of Hypertension (NSH) in 1991 (7) , the rates of awareness, treatment, and control were only 27%, 12%, and 3%, respectively. The International Collaborative Study of Cardiovascular Disease in ASIA (Inter ASIA) (8) , which was conducted in 2000-2001, showed an increase in prevalence, awareness, treatment and control of HT compared with the previous NSH. But the sampling method of Inter ASIA was not fully comparable with that of the previous NSH. In recent decades, lifestyles and socioeconomic factors have changed remarkably in China. Further clarification of the trends in prevalence, awareness, treatment and control of HT in the Chinese population are needed.
The China Multi-Center Study of Cardiovascular Epidemiology (China MUCA) is a long-term project supported by the Chinese government, with the purpose of monitoring the prevalence and trends for cardiovascular disease (CVD) and major risk factors (9) . From the results of the China MUCA Studies conducted in 1992-1994 and in 1998, we quantitatively analyzed the trends in prevalence, rate of awareness, treatment, and control of HT.
Methods

Study Design
Random cluster samples of 1,000 participants, half men and half women, aged 35 to 59 years, were selected from each of 13 study populations in China in two independent cross-sectional surveys: a survey conducted in 1992-1994, and another conducted in 1998. These study samples, which included 6 samples of farmers, 2 of factory workers, 4 of city residents and one of fishermen, had comparable data between the two surveys. A detailed description of the study population and design has been given in the previous paper (9) . There were 18,746 participants in 1992-1994, and 13,504 participants in 1998. The response rates were 89.5% and 85.0% for the surveys in 1992-1994 and 1998, respectively.
Surveys were carried out using internationally standardized methods (10, 11) , following a common protocol. Key investigators from each local center, including monitors, quality control persons and data input technicians, were trained and certified in advance of the survey according to a uniform protocol and operation manual. Both surveys asked respondents whether they had a past history of high BP, and whether they had previously used or were currently using (within the last 2 weeks) antihypertensive medication. Respondents who answered that they had a past history of high BP were considered "aware" hypertensives. Treatment status was assessed by the question of whether or not the person was currently using antihypertensive drugs.
BP Measurement
BP was measured 3 times on the right arm supported at heart level with a conventional sphygmomanometer (mercury) with the participant seated after an at least 5-min rest, and with 30 s of rest between each measurement. Systolic BP (SBP) was based on the first Korotkoff phase, and diastolic BP (DBP) on the fifth Korotkoff phase. The average of the three readings was used for analysis. HT was defined as SBP ≥140 mmHg, DBP ≥90 mmHg, and/or reported treatment with antihypertensive medications in the past 2 weeks. Rate of awareness was defined as the percentage of hypertensives reporting a prior diagnosis of HT. Rate of treatment was defined as the percentage of hypertensives with a history of antihypertensive drug therapy. Rate of control was defined as the percentage of hypertensives with blood pressure controlled under 140/90 mmHg.
Statistical Analysis
All data were recorded in uniform record forms, coded and entered twice into the computers by trained staff members at local centers, and then sent to the coordinating center of the Department of Epidemiology, Fu Wai Hospital, for final processing and analyses. Rate of awareness, treatment and control of HT were adjusted by the WHO world standard population. Data presented in this study were categorized by sex. SPSS 10.0 software was used for the statistical analysis. χ 2 test was used for categorized data, and values of p<0.05 were considered to indicate statistical significance.
Results
In 1998, the age-adjusted prevalence of HT was 24.0%, significantly greater than the prevalence of 22.7% in 1992-1994 (p<0.05, Table 1 ). During this period, the absolute increase was 2.3% in urban areas (p<0.05) and 0.7% in rural areas. Within the same survey, the HT prevalence, which tended to increase with aging, was higher in urban areas than in rural areas (23.1% to 22.1% in 1992-1994; 25.4% to 22.8% in 1998, p<0.05), and higher in men than in women (24.1% to 21.5% in 1992-1994; 26.5% to 21.9% in 1998, p<0.05).
In 1998, 42.6% of all hypertensive participants were aware of their HT, up by 5.3% compared to 1992-1994 (p<0.05, Table 2 ). In urban areas, the awareness of HT was 49.4% in 1992-1994, and 51.2% in 1998. In rural areas, only about 25% of hypertensives were aware of their HT in 1992-1994, but 34.2% were aware in 1998 (p<0.05). However, the rate of awareness in rural areas was still significantly lower than that in urban areas in 1998 (34.2% to 51.2%, p<0.05). The rates of awareness increased in both sexes, and were significantly higher in women than in men (39.8% for women vs. 34.9% for men in 1992-1994; 45.9% for women vs. 39.9% for men in 1998; both p<0.05) within the same survey. The awareness rose with aging in all groups except p<0.05, for the difference between surveys; p<0.05, for the difference between sex groups within the same survey; p<0.05, for the difference between rural areas and urban areas within the same survey. for the group aged 35-39 years in urban areas, and the greatest increase was seen in the group aged 45-49 years. In 1998, 31.1% of all hypertensive participants were receiving BP medication, compared with 27.3% in 1992-1994 (p<0.05, Table 3 ). Although there was a similar increase between urban areas (3.9%) and rural areas (3.4%), the rate of HT under treatment was still higher in urban areas than in rural areas in 1998 (41.4% vs. 21.4%, p<0.05). In both women and men, rates of treatment for HT improved from 1992-1994 to 1998 (from 31.4% to 34.8% in women, and from 23.3% to 28.0% in men, p<0.05) and rose with aging in all groups except the group aged 35-39 years in urban areas. However, it was higher in women than in men within the same survey.
From 1992-1994 to 1998, the rate of control for all hypertensives increased from 3.4% to 6.0% (p<0.05, Table 4 ). In urban areas it improved from 5.7% to 8.3% (p<0.05), while in rural areas it went from 1.5% to 3.6% (p<0.05). The control rate was higher in urban areas than in rural areas within the same survey (p<0.05). In both sexes, the control rates had improved from 1992-1994 to 1998, while there was no significant difference between women and men in 1998. All age groups experienced an increase in the rate of HT control except the group aged 35-39 years in urban areas.
Among treated hypertensives, the rate of control was 12.7% in 1992-1994, and 19.9% in 1998 (Table 4) . These values were almost threefold higher than those for all hypertensives in the respective surveys. The increase in control rate among treated hypertensives was greater in rural areas than in urban areas (11.5% to 4.4%), and there was no significant difference of control rate among treated hypertensives between urban areas and rural areas in 1998. In both women and men, the control rate among treated hypertensives increased markedly from 1992-1994 to 1998 (13.3% to 21.2% in women; 11.8% to 19.8% in men; p<0.05). The control rate for women was not significantly different from that of men within each survey. In urban areas, those aged 35-39 years had the lowest control rates; in rural areas, the control rate declined with aging.
Discussion
There have been three nation wide sampling surveys on HT in China (12) , with the most recent being in 1991. Over the past 10 years, rapid economic growth and associated socioeconomic changes have resulted in the emergence of numerous chronic, non-communicable diseases, including HT.
The China MUCA study is a long-term project supported by the Chinese government since 1981 for the purpose of monitoring the prevalence and trends for CVD and major risk factors. The study was expanded in 1991 and 1996, and currently includes 16 study populations. The populations 706 Hypertens Res Vol. 27, No. 10 (2004) Values are shown as in percentages; the number of participants is the same as in Table 2 . p<0.05, for the difference between surveys; p<0.05, for the difference between sex groups within the same survey; p<0.05, for the difference between rural areas and urban areas within the same survey. were selected based on the main geographical districts of China and the main characteristics of the populations located in different parts of China. Periodic surveys by random cluster sampling of each study population have been conducted using the internationally standardized methodology (10, 11) . For this reason, the data from the different surveys can be easily compared, resulting in accurate estimates and useful information for the control of HT in the Chinese population. Our study indicates that the prevalence of HT in the Chinese population has been rising over the past 5 years, while the levels of awareness, treatment and control of HT, though improved to some extent, remain low. The challenge posed Values are shown in percentages; the number of participants is the same as in Table 2 . p<0.05, for the difference between surveys; p<0.05, for the difference between sex groups within the same survey; p<0.05, for the difference between rural areas and urban areas within the same survey. by this continuously increasing prevalence in combination with lower levels of awareness, treatment and control of HT must be overcome for prevention and control of HT in China. Our results showed that the age-adjusted prevalence of HT in the middle aged population of China rose from 22.7% in 1992-1994 to 24.0% in 1998. This increase was probably the result of lifestyle changes in recent years, since BP has been strongly associated with body mass index, salt intake, and other diet-related factors (13). Wu et al. (5) reported that in the past 2 decades the prevalence of overweight and hypercholesterolemia increased significantly, the prevalence of alcohol consumption in men increased by 10%, and the prevalence of smoking was still over 60% in men. These increased prevalences may have been mainly related to the transitions in lifestyle. The difference in HT prevalence between urban areas and rural areas (14) is also a reflection of socio-economic change.
Burt et al. (15) reported that the rates of awareness and treatment in National Health and Nutrition Examination Surveys (NHANES III, in 1988-1991) reached 73% and 55% respectively, and showed a proportionally greater increase than those in NHANES II (in 1976-1980) in the United States. According to Hajjar and Kotchen's report (16) , the rate of treatment still remained increase from 1991 to 2000. Our study showed that the rates of awareness and treatment were 42.6% and 31.1% in 1998, respectively, which were much lower than those of the US. This implies that most hypertensive patients did not know they had suffered from high BP; only one third of them were under treatment. This may have partly contributed to the continuous increase in the absolute number of HT in the Chinese population. Further improvement in the knowledge and awareness of HT will be critical for the prevention and control of HT, since improving awareness is a prerequisite for treatment and control.
The control rate of HT showed an increasing trend from the early 1990s to the later 1990s. We also noted that the rate of control among treated HT was threefold higher than that for all hypertensive patients in the surveyed population, and for those hypertensives under treatment, the site and sex differences in control rates were no longer significant. This implies that the rate of control can be promoted as long as hypertensives in the community are under supervision. So, we should take every means to improve the detection and treatment of hypertensives in the population.
The rates of awareness, treatment and control in China were higher in urban areas than in rural areas. Such differences were very likely to be related to factors such as the easier access to medical care, more adequate supply of drugs, and better health education in urban areas than in rural areas. Furthermore, the lower income in rural areas is a barrier for treatment of HT. The Chinese government is launching a project to build up a cooperative medicare system in rural areas, which will cover 900 million farmers with medical financial assistance. This may help to decrease the differences in the near future.
The data showed that awareness and treatment were higher among women than men, which was also noted in other studies (17, 18) . On the other hand, the rates were lower in younger age groups, especially in the group aged 35-39 years, compared with older age groups. In Hajjar and Kotchen's report (16) , the rates of the group aged 18-39 years also showed a declining trend from 1988 to 2000. It is considered that women, as well as the old, may pay more attention to their health. The young, busying themselves with their ambitions, pay less attention to their health. Therefore, continuous health education is important for improving the awareness of male and young subjects.
The Chinese Hypertension League issued its guidelines for the prevention, detection and treatment of HT in 1999 (19) , and these have played an important role in the prevention and treatment of HT. At the same time, many health education programs have been initiated to improve the general awareness of HT (20) . Pharmaceutical companies have also been encouraged to support research and education as well as to provide medications to the indigent. Because HT requires lifetime treatment, subjects should also be encouraged to take home BP measurements. All of these efforts will be helpful for controlling HT. But the high prevalence of HT coupled with the low rates of awareness, treatment, and control is the austere reality, and this situation has been worsened by the regional imbalances. Further improving the awareness, treatment and control of hypertension is still one of the most important health issues in China.
In summary, despite progress in awareness and treatment, the rate of HT control still remains unacceptably low in China. HT is an important public health problem in China, and effective public health measures are urgently needed to enhance the rates of awareness and treatment.
